| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | 0.072 | 0.03 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | 0.071 | 0.03 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | 0.1 | 0.03 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.03 |
| mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | 0.072 | 0.03 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.03 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.04 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | -0.07 | 0.04 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.079 | 0.04 |